A research team of Professor Yoontae Lee and Jiho Park, a PhD candidate, from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH) recently discovered that a ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to diagnose and evaluate people with systemic lupus erythematosus (SLE). The ...
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand), showed efficacy in adults with active systemic lupus erythematosus (SLE) ...
Skin manifestations are common in patients with SLE. A recent study reported increased site-specific recurrence of cutaneous lupus erythematosus (CLE).1 While this study included a proportion of ...
Please provide your email address to receive an email when new articles are posted on . Last November, at the American College of Rheumatology Convergence 2023, several faculty members presented new ...
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease driven by both genetic susceptibility and environmental risk factors. Epigenetic processes, which lie at the intersection of ...
Clinical Trials Arena on MSN
SLE: Four trials to watch in 2026
As The European Lupus Society’s 15th annual soiree approaches, the Clinical Trials Arena team takes a look at four promising therapies in the SLE pipeline.
A previously unknown safety mechanism in our immune system keeps the body free from autoimmune diseases. Researchers from Karolinska Institutet have discovered that a cell in our inherited immune ...
Please provide your email address to receive an email when new articles are posted on . Patients with SLE can experience pain and fatigue daily, which makes life difficult. Something people unfamiliar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results